Viewing Study NCT04956302


Ignite Creation Date: 2025-12-25 @ 3:37 AM
Ignite Modification Date: 2026-05-26 @ 7:17 PM
Study NCT ID: NCT04956302
Status: TERMINATED
Last Update Posted: 2024-06-06
First Post: 2021-06-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Panobinostat in Combination With Daratumumab, Bortezomib and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma
Sponsor: Abdullah Khan
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Plasma Cell Myeloma View
None Refractory Plasma Cell Myeloma View
Keywords: